Minimal clinically important difference for the ocular surface disease index.
about
Associations between signs and symptoms of dry eye disease: a systematic reviewThe Effect of Tear Supplementation on Ocular Surface Sensations during the Interblink Interval in Patients with Dry EyeImpression cytology implicates cell autophagy in aqueous deficiency dry eye.Meibomian Gland Dysfunction in Type 2 Diabetic Patients.Meibomian gland dysfunction determines the severity of the dry eye conditions in visual display terminal workers.Age-related changes of the ocular surface: a hospital setting-based retrospective studyDiagnosing the severity of dry eye: a clear and practical algorithm.Acupuncture for the treatment of dry eye: a multicenter randomised controlled trial with active comparison intervention (artificial teardrops).Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.The relationship between clinical signs and dry eye symptoms.Efficacy and safety of two new formulations of artificial tears in subjects with dry eye disease: a 3-month, multicenter, active-controlled, randomized trial.Signs and Symptoms of Dry Eye in Keratoconus Patients: A Pilot Study.Challenges in the clinical measurement of ocular surface disease in glaucoma patients.Reduced Corneal Endothelial Cell Density in Patients With Dry Eye DiseaseEffects of preservative-free tafluprost on tear film osmolarity, tolerability, and intraocular pressure in previously treated patients with open-angle glaucoma.Comparison of Two Questionnaires for Dry Eye Symptom Assessment: The Ocular Surface Disease Index and the Symptom Assessment in Dry EyeOcular Manifestations of Acquired Immunodeficiency Syndrome.The association of vitamin D deficiency with tear break-up time and Schirmer testing in non-Sjögren dry eye.Understanding Ocular Discomfort and Dryness Using the Pain Sensitivity Questionnaire.Evaluation of a novel eyelid-warming device in meibomian gland dysfunction unresponsive to traditional warm compress treatment: an in vivo confocal study.Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease--A Prospective, Multicenter Noninterventional Study.Impact of Chronic Smoking on Meibomian Gland Dysfunction.Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma MedicationsEvaluation of Dry Eye and Meibomian Gland Dysfunction in Teenagers with Myopia through Noninvasive KeratographCorneal Dendritic Cell Density Is Associated with Subbasal Nerve Plexus Features, Ocular Surface Disease Index, and Serum Vitamin D in Evaporative Dry Eye Disease.Minimal clinically important differences for the EQ-5D and QWB-SA in Post-traumatic Stress Disorder (PTSD): results from a Doubly Randomized Preference Trial (DRPT).Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.A Clinical Trial Comparing the Safety and Efficacy of Topical Tacrolimus versus Methylprednisolone in Ocular Graft-versus-Host DiseaseInfluence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma.Evaluation of ocular surface disease in patients with glaucomaInternational Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I).Photorefractive keratectomy for patients with preoperative low Schirmer test value.What is the value of incorporating tear osmolarity measurement in assessing patient response to therapy in dry eye disease?Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye.Discordant Dry Eye Disease (An American Ophthalmological Society Thesis).Tear osmolarity and dry eye symptoms in diabetics.Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trialClinical Objective Dry Eye Tests in a Population of Tannery Workers in North India.Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren's Syndrome.
P2860
Q26781979-89A268D9-72ED-44E5-BE49-01F7CDA974ADQ28547448-BE823B48-0610-46BE-BFF8-FCCFA394BE45Q33621122-B0A25473-7F36-418D-B5B6-E62E427AD001Q33737599-A4A3E037-5DE0-4959-908A-3CC67E251347Q34075562-5E76B611-FD8E-4C1B-B18C-5CA2B3838487Q34087380-C3745DC5-6679-46C5-94F8-8FE3E8999C6EQ34092386-6AC4A086-8BDC-4CEB-BB0D-47114684FE0EQ34277339-6AB61D45-2792-4E7C-91DD-8BE67F117496Q34357225-155B0585-7B09-424F-9123-D2ACCED6ACFFQ34769313-405606B9-CE86-4E7A-8D61-E06541DFC204Q35208749-19D20999-438E-4C6D-8CBB-9CF747D27543Q35507058-C0D1083C-E750-4003-B6E6-CED9E6E998A9Q35509281-1B067EA6-F9AE-4324-AA41-2794ABD0D78CQ35555771-317041AE-30EF-4E47-8760-479D8D01A283Q35579883-ABDE3852-E4E5-4F32-89A4-A36AA30D5BC8Q35682054-F05161BC-FE8C-4DB2-948E-9D7B6F714EB4Q35798154-904BB2B5-E74A-4D7D-A58E-CE6D2A28D5B5Q35904905-493010BB-3C97-4CB0-B178-532DA7DAF605Q35970088-C6CA192C-7F34-4BCA-9D0E-17CAF86F10A1Q36006287-2B914E06-5ABD-465E-832F-2583648D6FF3Q36012651-B145DA36-E0AC-4B8D-94B4-E29CA4B00E7BQ36141209-1C35EE50-6D63-48CA-9CD0-9506CC0C767EQ36234813-6D7C9288-0549-4152-AF4B-5B8CBA01E3D5Q36498525-0BC61E38-CDBD-4FF9-8B00-915C2ADECD3EQ36531610-1E7D56B0-2C2D-48DE-AC0A-753EA34C311AQ36556824-84DC7C5E-B785-4ABF-A985-D20016255083Q36794039-539CA625-581C-43E9-BE98-12B12E6FA795Q36908446-7C8F3559-3063-40B7-B008-B36566F98CA3Q37038747-5B73F2FD-C0A7-473C-8FC3-116A43050AE0Q37067698-70210C2A-FA78-49FA-AAEC-0DC9822EDB8EQ37281821-2AEE72CD-D6AC-4D1F-B9EF-2EC95D2A9E00Q37365681-62039233-BAB5-4C54-AB0C-797957CAF058Q37390513-34394EB0-B4FA-4C07-9188-28B8589789CAQ37397203-E4A50FAB-541D-4797-90F5-351136857F84Q37485838-2872C816-CBE9-4CA2-94E9-600FE0C6308DQ37536295-3B616C93-A5EB-44CA-A84C-15AD0A030058Q37641850-C0EF72DC-BB1E-4F27-848D-8D95E6045519Q39835086-714EDC38-5E08-44A8-B10B-35F125637256Q40965490-A761E8A2-3D5E-45A5-BA14-85CB4861D4D9Q41540895-035F5D08-EC9A-43FC-9CDB-178D6C4BCEF1
P2860
Minimal clinically important difference for the ocular surface disease index.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimal clinically important difference for the ocular surface disease index.
@en
Minimal clinically important difference for the ocular surface disease index.
@nl
type
label
Minimal clinically important difference for the ocular surface disease index.
@en
Minimal clinically important difference for the ocular surface disease index.
@nl
prefLabel
Minimal clinically important difference for the ocular surface disease index.
@en
Minimal clinically important difference for the ocular surface disease index.
@nl
P2093
P1433
P1476
Minimal clinically important difference for the ocular surface disease index.
@en
P2093
David R Mink
Henry D Perry
John G Walt
Kimberly L Miller
Penny A Asbell
Sacha Satram-Hoang
Stephen C Pflugfelder
Steven E Wilson
P304
P356
10.1001/ARCHOPHTHALMOL.2009.356
P407
P577
2010-01-01T00:00:00Z